1. Evolocumab use and LDL-C lowering in a cohort of european patients with familial hypercholesterolemia (FH) - Results from the Heymans study. (August 2021) Authors: Sibartie, M.; Dhalwani, N.; Bridges, I.; Ebenbichler, C.; Filardi, P. Peronne; Vogt, A.; Bruckert, E. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗